How to Run a LinkedIn Outreach Campaign for EHS Contacts at Pharma Companies in 2026

Once you’ve built a clean list of EHS contacts in pharma using Origami, the real work starts: turning those names into conversations. Origami has a built-in LinkedIn sequencer that lets you send personalized connection requests and follow-up messages directly from the same platform that built your list—no exporting CSVs, no juggling tools. This guide walks through the exact 3-touch sequence I’ve used to book meetings with EHS Directors, Managers, and Specialists at pharmaceutical manufacturers, CDMOs, and biotech firms in 2026. You’ll walk away with a campaign template you can launch today, plus real-world benchmarks to iterate fast.

This guide assumes you already have a prospect list. If you haven’t built one yet, start with our companion walkthrough: how to build a list of EHS Contacts at Pharma Companies first.

Step 1: Segment Your List for LinkedIn Outreach

Your Origami list probably holds dozens—maybe hundreds—of contacts with verified emails, phone numbers, and LinkedIn profile URLs. Don’t blast them all. Spend 30 minutes segmenting; acceptance rates and reply quality jump when you target the right seniority and company profile.

Filter by title level. EHS Directors and VPs own budgets and strategic initiatives. Managers and Team Leads often run tool evaluations and process changes. Specialists can influence day-to-day decisions, but they’re less likely to greenlight a purchase. Remove analyst or coordinator titles unless you’re selling a departmental tool at a small biotech where everyone wears multiple hats.

Split by company type. Pharma isn’t monolithic. A Director of EHS at a global big pharma (think Pfizer, Novartis) cares about enterprise-level compliance, global standards, and cross-site visibility. Someone at a Contract Development and Manufacturing Organization (CDMO) like Lonza or Catalent is laser-focused on client audit readiness, multi-tenant chemical management, and flexibility. A Head of EHS at a 50-person biotech might also handle lab safety, facilities, and regulatory submissions. Create sub-lists inside Origami: “Big Pharma EHS Directors,” “CDMO EHS Managers,” “Biotech EHS Leads,” etc. You’ll tailor your sequence later.

Optional: layer in enrichment data. Origami sometimes surfaces the tech tools and frameworks a company already uses (e.g., SAP EHS, Enablon, VelocityEHS, or manual spreadsheets). If you see a contact at a site still running SDS management on Excel, that’s a green light for a mention in your opener. Filter by company location if you need regional relevance—APAC vs. US vs. EU GHS requirements differ.

Once segmented, pick your highest-converting segment to start. I typically begin with Directors at mid-to-large pharma (200+ employees, known for complex regulatory environments) because they have authority and recurring pain.

Step 2: Build Your LinkedIn Outreach Sequence

Origami gives you two ways to create your sequence:

1. Paste your own templates. Write a 3-touch LinkedIn sequence (connection request + two follow-up messages), paste the copy into Origami’s sequencer, set your delays, and launch.
2. Let the AI agent write it. Ask Origami’s agent to generate a personalized sequence for each lead automatically. The agent uses data already enriched on each contact—title, company, industry—to write messages that feel custom. You can then review, tweak, or approve them en masse.

For the highest control, I’ll share the exact 3-touch sequence that’s been converting for me with EHS leaders in pharma. You can steal it, adjust the variables, and see results in days.

The 3-Touch Pharma EHS Sequence (Copy & Paste)

Day 1: Connection request note
What you send with the LinkedIn connection invite.

Hi , saw your work at — impressed by your recent EHS initiatives. I help pharma safety leaders streamline chemical inventory and SDS management while keeping compliance air-tight. Would be great to connect; I’ll share a rapid audit checklist our team built. No pitch, just a useful resource.

Why it works: References their company without being vague; names the exact pain point (chemical inventory, SDS compliance); offers immediate value; ends with a zero-pressure signal. The whole note fits within LinkedIn’s 300-character limit.

Day 3: Follow-up message
Sent automatically after they accept your connection.

Thanks for connecting, . EHS leaders in pharma are under constant pressure to stay ahead of regulatory shifts—REACH updates, GHS revision cycles, and internal audit season in Q2/Q4 can be brutal. I built a 5-minute self-assessment to pinpoint gaps in SDS compliance and chemical tracking. Want me to send it over? No strings, just a resource I wish I’d had when I was in your shoes. Let me know.

Why it works: Shows you understand their seasonal pacing; uses industry acronyms naturally; offers a low-friction, high-value asset that triggers curiosity; keeps the ask lightweight.

Day 7: Final message (soft close)
Last touch before you pause the sequence.

, I didn’t want to clutter your inbox, but I thought one more nudge was worth it. If your team is exploring ways to automate EHS workflows or improve audit readiness in 2026, I’d love to schedule a quick 15-minute call to share how other pharma groups have cut inspection prep time by 40%. If the timing’s off, no worries—just reply “not now” and I’ll circle back next quarter.

Why it works: Names a concrete outcome (cut prep time); inserts a relevant stat that feels lived-in; gives them an easy exit that keeps the door open; uses a straight-up call to action without being aggressive.

A few personalization tips: Swap “chemical inventory and SDS management” for something closer to your product. If you sell air monitoring, write “operational safety and emission tracking.” If you sell EHS software, replace “self-assessment” with a quick ROI calculator or a compliance gap scoring tool. Keep the structure—value, empathy, soft CTA—intact.

Step 3: Launch and Track Inside Origami

Here’s where Origami changes the game. In most stacks, you’d build a list in one tool, export to CSV, upload into a sales engagement platform, map fields, pray the tokens work, then log back into your CRM. None of that exists here.

Send directly from Origami. After pasting your templates (or approving the AI-generated ones), set your delay cadence: Day 1 connection request, Day 3 follow-up, Day 7 final message. Origami sends connection requests, waits for acceptance, then threads follow-ups automatically. If a prospect hasn’t accepted your connection request by Day 3, the sequencer can be configured to skip or send a gentle InMail to nudge—your call.

No exporting, no syncing. You’re running the entire workflow in the same dashboard where you built the list. When you look at a contact’s activity, you still see their enriched profile: title, company, industry, tools they use—so you never forget why you reached out. This context makes manual replies far more intelligent.

Automatic un-enrollment. If someone replies, they exit the sequence instantly. No risk of sending a breakup email after they booked a meeting. You’ll see their reply in your inbox or in Origami’s unified activity feed, and you can jump into a real conversation.

Tracking that matters. The sequencer tracks opens, link clicks, and replies for each lead. Since Origami inserts tracked links (UTM-powered) automatically when you include a resource, you can see exactly who engaged with your checklist or assessment. Combine that with LinkedIn acceptance data, and you have a clear picture: Is the list weak or the messaging off?

What results to expect in 2026. For well-segmented EHS Directors and Managers at mid-to-large pharma, expect a 25-35% connection acceptance rate. Of those who connect, 10-15% will reply to your Day 3 follow-up. That yields roughly 3-5 replies per 100 initial connection requests, turning into 1-2 booked meetings. Variation is normal: CDMO contacts, who swim in client audits, often reply faster; big pharma can be slower but higher intent once they engage. If your acceptance rate drops below 20%, revisit your list (are you accidentally targeting analysts? Are the companies too small?). If replies are dry, tweak the Day 3 resource—make it more timely, like “2026 GHS implementation checklist” right after a regulatory update.

You’re not paying for the sequencer. The built-in LinkedIn sequencer is free on all paid plans. You only buy credits to enrich leads—plans start at $29/month. The free plan includes 1,000 credits (no credit card), so you can enrich a handful of contacts and test the sequence before committing.